Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
FAAM 2016: Experts discuss advancements in diagnosis, management of food allergies and anaphylaxis

FAAM 2016: Experts discuss advancements in diagnosis, management of food allergies and anaphylaxis

Penicillin allergy testing: an interview with Dr. Eric Macy

Penicillin allergy testing: an interview with Dr. Eric Macy

Study finds oral immunotherapy safe, effective at suppressing peanut allergy in preschool children

Study finds oral immunotherapy safe, effective at suppressing peanut allergy in preschool children

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

Researchers aim to improve medical treatment for people with insect venom allergy

Researchers aim to improve medical treatment for people with insect venom allergy

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

Food-triggered atopic dermatitis in children may lead to life-threatening anaphylaxis risk

Food-triggered atopic dermatitis in children may lead to life-threatening anaphylaxis risk

Common misconception about penicillin allergies

Common misconception about penicillin allergies

New study finds no increase in food-specific IgE levels linked to food allergies

New study finds no increase in food-specific IgE levels linked to food allergies

Researchers observe worrisome increase in anaphylaxis rate

Researchers observe worrisome increase in anaphylaxis rate

Vanderbilt's A.S.A.P sees increase in number of patients treated for alpha-gal syndrome

Vanderbilt's A.S.A.P sees increase in number of patients treated for alpha-gal syndrome

Cinqair (reslizumab) approved for treatment of severe asthma

Cinqair (reslizumab) approved for treatment of severe asthma

Anthim (obiltoxaximab) injection approved for treatment of inhalational anthrax

Anthim (obiltoxaximab) injection approved for treatment of inhalational anthrax

Baxalta seeks FDA approval for ADYNOVATE to treat children with hemophilia A and for use in surgical settings

Baxalta seeks FDA approval for ADYNOVATE to treat children with hemophilia A and for use in surgical settings

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Simple method to purify cashew allergens could help scientists better understand allergic reactions

Simple method to purify cashew allergens could help scientists better understand allergic reactions

Lilly receives FDA approval for Humulin R U-500 KwikPen

Lilly receives FDA approval for Humulin R U-500 KwikPen

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

Study finds communication gap between doctors and parents in management of children's food allergies

Study finds communication gap between doctors and parents in management of children's food allergies